Presentation TVT 2016 TVT 1063: What Is the Optimal Treatment for Residual Commissural Jet Following MitraClip? Ventricular Septal Defect Occluder Device vs Gore CARDIOFORM Presenter: Yoshifumi Nakajima, MD June 16, 2016
Presentation TVT 2016 The Minimalist TAVR Credo: Keep It Simple! Impact on Clinical Pathway Efficiencies and Outcomes Presenter: Vasilis Babaliaros June 16, 2016
Presentation TVT 2016 TVT 1036: Concurrent Transcatheter Double Valve Replacement: First Report of Sapien 3 Implantation in Native Aortic and Mitral Annuli in the Same Setting Presenter: Vikas Aggarwal, MD June 16, 2016
Presentation TVT 2016 TVT 1123: TAVR Valve Used to Treat Native Mitral Regurgitation A Hybrid Surgical Transcatheter Approach Presenter: Creighton W. Don June 16, 2016
Presentation TVT 2016 Appropriate Use of TAVR Now and in the Future: A Surgeons Perspective Presenter: Neil E. Moat June 16, 2016
Presentation TVT 2016 The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet? Presenter: Martin B. Leon June 16, 2016
Presentation Incidence, Predictors, and Outcome of Patients Developing Infective Endocarditis (IE) Following Transfemoral TAVR Presenter: Norman Mangner June 14, 2016
Presentation SOLACI 2016 TAVI - Indicações E Resultados Atuais Presenter: Luiz Antonio Carvalho June 10, 2016
Presentation SOLACI 2016 Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices Presenter: Martin B. Leon June 10, 2016
Presentation SOLACI 2016 Software “syngo Aortic Valve Guidance” para procedimentos de TAVI Presenter: Ari Mandil June 09, 2016
Presentation SOLACI 2016 Complex Cases in TAVI: Our Experience With the Last Generation Valves Presenter: Vin?cius Esteves June 09, 2016
Presentation Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement Presenter: Giovanni Esposito June 06, 2016
Presentation Choice of Treatment for Aortic Valve Stenosis in the Era of TAVR in Eastern Denmark (2005-2015) Presenter: Ole De Backer June 01, 2016
Presentation EuroPCR 2016 Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome Presenter: Patrick Serruys May 20, 2016
Presentation EuroPCR 2016 A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement Presenter: Alexandra Lansky May 20, 2016
Presentation EuroPCR 2016 Impact of Coronary Artery Disease on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation: An Age- and Sex-Matched Cohort Study Presenter: Anna Franzone May 19, 2016
Presentation EuroPCR 2016 First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation Presenter: Danny Dvir May 19, 2016
Presentation EuroPCR 2016 Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification Presenter: Mayra Guerrero May 18, 2016